Open Angle Glaucoma
Showing NaN - NaN of 6
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Xalacom
- +2 more
-
Birmingham, Alabama
- +63 more
Feb 17, 2021
Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (1 drop of 0.375% SYL040012 (bamosiran), 1 drop of 0.750% SYL040012
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- 1 drop of 0.375% SYL040012 (bamosiran)
- +4 more
-
Artesia, California
- +20 more
Dec 11, 2020
Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- PG324 Ophthalmic Solution 0.01%
- +3 more
-
Artesia, California
- +22 more
May 14, 2019
Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic
Completed
- Ocular Hypertension
- Open Angle Glaucoma
- AR-13324 Ophthalmic Solution 0.01%
- +2 more
-
Artesia, California
- +21 more
Mar 19, 2018
Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- PG286 Ophthalmic Solution 0.5%
- +2 more
-
Artesia, California
- +20 more
Feb 17, 2014